Sam Ghebrehewet

1.6k total citations · 1 hit paper
42 papers, 770 citations indexed

About

Sam Ghebrehewet is a scholar working on Epidemiology, Health and General Health Professions. According to data from OpenAlex, Sam Ghebrehewet has authored 42 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 12 papers in Health and 10 papers in General Health Professions. Recurrent topics in Sam Ghebrehewet's work include Virology and Viral Diseases (10 papers), Vaccine Coverage and Hesitancy (10 papers) and Influenza Virus Research Studies (8 papers). Sam Ghebrehewet is often cited by papers focused on Virology and Viral Diseases (10 papers), Vaccine Coverage and Hesitancy (10 papers) and Influenza Virus Research Studies (8 papers). Sam Ghebrehewet collaborates with scholars based in United Kingdom, France and Iran. Sam Ghebrehewet's co-authors include Peter MacPherson, Soheil Ebrahimpour, Mohammad Barary, Veerendra Koppolu, Mostafa Javanian, A. Keenan, Antonia Ho, Roberto Vivancos, Daniel Hungerford and Philip McHale and has published in prestigious journals such as BMJ, The Lancet Infectious Diseases and Journal of Epidemiology & Community Health.

In The Last Decade

Sam Ghebrehewet

37 papers receiving 751 citations

Hit Papers

A brief review of influen... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sam Ghebrehewet United Kingdom 13 493 240 194 115 108 42 770
Emily Lutterloh United States 14 479 1.0× 153 0.6× 822 4.2× 78 0.7× 143 1.3× 33 1.1k
Daniela Rivetti Italy 12 1.1k 2.3× 253 1.1× 243 1.3× 196 1.7× 120 1.1× 26 1.5k
Joseph A. Lewnard United States 13 333 0.7× 89 0.4× 302 1.6× 59 0.5× 69 0.6× 28 869
Ayesha J Verrall New Zealand 17 303 0.6× 72 0.3× 431 2.2× 232 2.0× 69 0.6× 28 886
Stefania Iannazzo Italy 18 543 1.1× 390 1.6× 196 1.0× 69 0.6× 14 0.1× 41 853
Valentina Picot France 15 242 0.5× 86 0.4× 239 1.2× 68 0.6× 56 0.5× 43 716
Vipin M. Vashishtha India 20 300 0.6× 239 1.0× 418 2.2× 67 0.6× 51 0.5× 70 870
Jessie R. Chung United States 22 1.6k 3.3× 323 1.3× 551 2.8× 261 2.3× 157 1.5× 56 1.9k
Sophie Gubbels Denmark 14 244 0.5× 111 0.5× 703 3.6× 52 0.5× 62 0.6× 33 1.1k

Countries citing papers authored by Sam Ghebrehewet

Since Specialization
Citations

This map shows the geographic impact of Sam Ghebrehewet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Ghebrehewet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Ghebrehewet more than expected).

Fields of papers citing papers by Sam Ghebrehewet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Ghebrehewet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Ghebrehewet. The network helps show where Sam Ghebrehewet may publish in the future.

Co-authorship network of co-authors of Sam Ghebrehewet

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Ghebrehewet. A scholar is included among the top collaborators of Sam Ghebrehewet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Ghebrehewet. Sam Ghebrehewet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gibbons, Cheryl, Ting Shi, Christopher Sullivan, et al.. (2025). RSV Vaccination Programme for Older Adults: A Scotland-Wide Study on RSVpreF Vaccine Safety. Vaccines. 13(11). 1088–1088.
2.
McQueenie, Ross, Safraj Shahul Hameed, Cheryl Gibbons, et al.. (2025). Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis. The Lancet Infectious Diseases. 26(4). 362–373.
3.
Hameed, Safraj Shahul, et al.. (2025). Early evidence of RSV vaccination impact on hospitalisation rates of older people in Scotland. The Lancet Infectious Diseases. 25(3). 256–258. 6 indexed citations
5.
Tulloch, John, et al.. (2023). COVID-19 vaccine hesitancy in care home staff: A survey of Liverpool care homes. Vaccine. 41(7). 1290–1294. 2 indexed citations
6.
7.
Ghebrehewet, Sam, Anthony Harries, Merav Kliner, et al.. (2019). Adapting the Structured Operational Research Training Initiative (SORT IT) for high-income countries. Public Health Action. 9(2). 69–71.
8.
MacPherson, Peter, Andrew J. Fox, Sam Ghebrehewet, et al.. (2017). An Outbreak of Pseudomonas Aeruginosa Infection Linked to a “Black Friday” Piercing Event. PLoS Currents. 9. 3 indexed citations
9.
Kliner, Merav, A. Keenan, David Sinclair, Sam Ghebrehewet, & Paul Garner. (2016). Influenza vaccination for healthcare workers in the UK: appraisal of systematic reviews and policy options. BMJ Open. 6(9). e012149–e012149. 24 indexed citations
10.
Ghebrehewet, Sam, et al.. (2016). The economic cost of measles: Healthcare, public health and societal costs of the 2012–13 outbreak in Merseyside, UK. Vaccine. 34(15). 1823–1831. 24 indexed citations
11.
Ghebrehewet, Sam & Alexander Stewart. (2016). Who is involved in health protection?. Oxford University Press eBooks.
12.
Ghebrehewet, Sam, et al.. (2016). What is health protection?. Oxford University Press eBooks. 1 indexed citations
13.
McHale, Philip, A. Keenan, & Sam Ghebrehewet. (2015). Reasons for measles cases not being vaccinated with MMR: investigation into parents' and carers' views following a large measles outbreak. Epidemiology and Infection. 144(4). 870–875. 33 indexed citations
14.
Hungerford, Daniel, et al.. (2015). Effect of socioeconomic deprivation on uptake of measles, mumps and rubella vaccination in Liverpool, UK over 16 years: a longitudinal ecological study. Epidemiology and Infection. 144(6). 1201–1211. 41 indexed citations
15.
Hungerford, Daniel, Paul Cleary, Sam Ghebrehewet, A. Keenan, & Roberto Vivancos. (2013). Risk factors for transmission of measles during an outbreak: matched case–control study. Journal of Hospital Infection. 86(2). 138–143. 12 indexed citations
16.
Ghebrehewet, Sam, et al.. (2012). Outbreak of measles in Central and Eastern Cheshire, UK, October 2008–February 2009. Epidemiology and Infection. 141(9). 1849–1856. 12 indexed citations
17.
Ghebrehewet, Sam, J Hart, Sandra P. Whiteside, et al.. (2009). Probable zoonotic transmission of verocytotoxigenic Escherichia coli O157 by dogs. Veterinary Record. 164(10). 304–305. 11 indexed citations
18.
Ghebrehewet, Sam, et al.. (2008). Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs). Human Vaccines. 4(4). 280–285. 12 indexed citations
19.
Ghebrehewet, Sam, et al.. (2003). MMR vaccine uptake rates: a data validation study.. PubMed. 6(2). 144–6. 6 indexed citations
20.
Ghebrehewet, Sam. (2002). Provision of services to asylum seekers. Are there lessons from the experience with Kosovan refugees?. Journal of Epidemiology & Community Health. 56(3). 223–226. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026